S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
Log in

NASDAQ:AXLA - Axcella Health Stock Price, Forecast & News

$3.55
+0.01 (+0.28 %)
(As of 12/12/2019 04:00 PM ET)
Today's Range
$3.38
Now: $3.55
$3.63
50-Day Range
$3.08
MA: $4.24
$5.96
52-Week Range
$2.76
Now: $3.55
$15.99
Volume20,128 shs
Average Volume36,030 shs
Market Capitalization$82.05 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for Axcella Health Inc.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AXLA
CUSIPN/A
CIKN/A
Phone857-320-2200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Net Income$-36,070,000.00

Miscellaneous

EmployeesN/A
Market Cap$82.05 million
Next Earnings Date2/11/2020 (Estimated)
OptionableNot Optionable

Receive AXLA News and Ratings via Email

Sign-up to receive the latest news and ratings for AXLA and its competitors with MarketBeat's FREE daily newsletter.


Axcella Health (NASDAQ:AXLA) Frequently Asked Questions

What is Axcella Health's stock symbol?

Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."

How were Axcella Health's earnings last quarter?

Axcella Health Inc (NASDAQ:AXLA) announced its earnings results on Tuesday, November, 12th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.71) by $0.04. View Axcella Health's Earnings History.

When is Axcella Health's next earnings date?

Axcella Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 11th 2020. View Earnings Estimates for Axcella Health.

What price target have analysts set for AXLA?

4 Wall Street analysts have issued 12 month price objectives for Axcella Health's shares. Their forecasts range from $20.00 to $25.00. On average, they anticipate Axcella Health's stock price to reach $22.00 in the next year. This suggests a possible upside of 519.7% from the stock's current price. View Analyst Price Targets for Axcella Health.

What is the consensus analysts' recommendation for Axcella Health?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Axcella Health.

Has Axcella Health been receiving favorable news coverage?

Media coverage about AXLA stock has been trending extremely negative recently, according to InfoTrie. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Axcella Health earned a media sentiment score of -4.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an effect on the stock's share price in the next few days. View News Stories for Axcella Health.

Are investors shorting Axcella Health?

Axcella Health saw a decrease in short interest in November. As of November 29th, there was short interest totalling 32,100 shares, a decrease of 26.0% from the November 14th total of 43,400 shares. Based on an average daily trading volume, of 29,200 shares, the short-interest ratio is currently 1.1 days. Approximately 0.4% of the shares of the stock are sold short. View Axcella Health's Current Options Chain.

Who are some of Axcella Health's key competitors?

What other stocks do shareholders of Axcella Health own?

When did Axcella Health IPO?

(AXLA) raised $76 million in an IPO on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink served as the underwriters for the IPO.

When did Axcella Health's lock-up period expire?

Axcella Health's lock-up period expired on Tuesday, November 5th. Axcella Health had issued 3,571,428 shares in its public offering on May 9th. The total size of the offering was $71,428,560 based on an initial share price of $20.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the end of the lock-up period.

Who are Axcella Health's major shareholders?

Axcella Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Millennium Management LLC (0.29%), Chilton Investment Co. LLC (0.19%) and Squarepoint Ops LLC (0.04%). Company insiders that own Axcella Health stock include D Clay Bretches, David R Epstein and Ventures Fund Iv LP Flagship. View Institutional Ownership Trends for Axcella Health.

Which institutional investors are selling Axcella Health stock?

AXLA stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC and Squarepoint Ops LLC. View Insider Buying and Selling for Axcella Health.

Which institutional investors are buying Axcella Health stock?

AXLA stock was bought by a variety of institutional investors in the last quarter, including Chilton Investment Co. LLC. Company insiders that have bought Axcella Health stock in the last two years include D Clay Bretches, David R Epstein and Ventures Fund Iv LP Flagship. View Insider Buying and Selling for Axcella Health.

How do I buy shares of Axcella Health?

Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Axcella Health's stock price today?

One share of AXLA stock can currently be purchased for approximately $3.55.

How big of a company is Axcella Health?

Axcella Health has a market capitalization of $82.05 million. View Additional Information About Axcella Health.

What is Axcella Health's official website?

The official website for Axcella Health is http://www.axcellahealth.com/.

How can I contact Axcella Health?

Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-320-2200.


MarketBeat Community Rating for Axcella Health (NASDAQ AXLA)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  37 (Vote Underperform)
Total Votes:  69
MarketBeat's community ratings are surveys of what our community members think about Axcella Health and other stocks. Vote "Outperform" if you believe AXLA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AXLA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel